Thermon (THR) Director Awarded 1,008 Shares, Ownership Now 34,104
Rhea-AI Filing Summary
Thermon Group Holdings, Inc. (THR) reported a Form 4 showing a director-level insider award under the company’s Non-Employee Director Compensation Program. On 10/01/2025 Roger L. Fix was granted 1,008 shares of Common Stock at an indicated price of $27.28 per share. After the award, Mr. Fix is reported to beneficially own 34,104 shares of THR. The filing identifies Mr. Fix as a director and was signed on behalf of the reporting person by an attorney-in-fact on 10/02/2025. The Form 4 shows a routine equity award to a non-employee director and does not disclose option exercises, derivative positions, or additional material transactions.
Positive
- Director alignment via equity: Roger L. Fix received 1,008 shares under the Non-Employee Director Compensation Program, aligning interests with shareholders.
- Transparent disclosure: Transaction date (10/01/2025), grant price ($27.28), and post-award beneficial ownership (34,104 shares) are explicitly reported.
Negative
- None.
Insights
TL;DR: Director received a routine equity award of 1,008 shares; ownership post-award equals 34,104 shares.
The Form 4 documents a standard non-employee director equity grant rather than a purchase or sale. The grant size and price are disclosed explicitly, and the resulting beneficial ownership is modest relative to typical public-company share counts. There are no derivative instruments reported, and no changes to debt or operating results disclosed. This filing is informational for governance and insider alignment but carries limited immediate financial impact.
TL;DR: Non-employee director compensation awarded in stock; filing aligns with routine governance disclosure requirements.
The Form 4 indicates the company uses equity grants to compensate non-employee directors, disclosed per Section 16 filing rules. The reporting person is identified as a director and the transaction is labeled as an award under the issuer’s director compensation program. The filing is signed by an attorney-in-fact, meeting procedural requirements. No governance red flags or departures from standard disclosure practices are evident in the document.